craschworks

Note that this is not unusual! The cops were following a standard operating procedure. Our country has become a police state.

http://www.reuters.com/article/idUSTRE62O08U20100325

Last week, a Columbia, Missouri, drug raid captured on video went viral. As of this morning, the video had garnered 950,000 views on YouTube. It has lit up message boards, blogs, and discussion groups around the Web, unleashing anger, resentment and even, regrettably, calls for violence against the police officers who conducted the raid. I’ve been writing about and researching these raids for about five years, including raids that claimed the lives of innocent children, grandmothers, college students, and bystanders. Innocent families have been terrorized by cops who raided on bad information, or who raided the wrong home due to some careless mistake. There’s never been a reaction like this one.

But despite all the anger the raid has inspired, the only thing unusual thing here is that the raid was captured on video, and that the video was subsequently released to the press. Everything else was routine. Save for the outrage coming from Columbia residents themselves, therefore, the mass anger directed at the Columbia Police Department over the last week is misdirected. Raids just like the one captured in the video happen 100-150 times every day in America. Those angered by that video should probably look to their own communities. Odds are pretty good that your local police department is doing the same thing.

Despite months of talk therapy, the nightmares continued, and Bledsoe grew desperate. Then “something almost miraculous” happened, he says. An online search brought him to a unique study of the banned drug MDMA (3,4-methylenedioxymethamphetamine), well known as the street drug ecstasy. The 21-patient study, sponsored by the nonprofit Multidisciplinary Association for Psychedelic Studies (MAPS), launched in 2004 as the first U.S. clinical trial of a psychedelic drug in 35 years.

After several bond-building sessions with psychiatrist and study leader Michael Mithoefer and a co-therapist, Bledsoe swallowed a white tablet, donned eyeshades and reclined in Mithoefer’s comfortable Charleston, S.C., office. Over the next eight hours, Bledsoe revisited the explosion and recounted the trauma to Mithoefer. After two more MDMA-assisted psychotherapy sessions, Bledsoe says his PTSD symptoms were “completely eliminated.”

This weekend at a MAPS-sponsored meeting here, Mithoefer reported similar results for nearly all of the trial’s participants. After two or three MDMA sessions, patients who received MDMA experienced huge drops in symptoms as measured by a standard PTSD scale. At baseline, study patients had an average Clinician-Administered PTSD Scale (CAPS) score of 79, but after MDMA-assisted therapy, CAPS scores dropped to 23.4 in the 13-person MDMA group, whereas an eight-person placebo group averaged a score of 60. (Later, seven of eight placebo patients chose to receive MDMA as well.)

In the face of a growing number of deaths and cases of HIV linked to drug abuse, the Portuguese government in 2001 tried a new tack to get a handle on the problem—it decriminalized the use and possession of heroin, cocaine, marijuana, LSD and other illicit street drugs. The theory: focusing on treatment and prevention instead of jailing users would decrease the number of deaths and infections.

Five years later, the number of deaths from street drug overdoses dropped from around 400 to 290 annually, and the number of new HIV cases caused by using dirty needles to inject heroin, cocaine and other illegal substances plummeted from nearly 1,400 in 2000 to about 400 in 2006,  according to a report released recently by the Cato Institute, a Washington, D.C, libertarian think tank.

 ”Now instead of being put into prison, addicts are going to treatment centers and they’re learning how to control their drug usage or getting off drugs entirely,” report author Glenn Greenwald, a former New York State constitutional litigator, said during a press briefing at Cato last week.

I was curious about what a conference dedicated to entheogens might be like, and curious about the people who would attend such a conference, so I accepted the invitation to speak. It was as I was preparing my presentation for the illuminati of the psychedelic world that I realized what a profound, and positive impact my psychedelic experiences had had on my life, and in particular, on my sex life. In an aha! moment, it became clear that psychedelics had been perhaps my greatest sex educator.

The study, which took place from 2001 to 2005, and was published in 2006 in the journal Psychopharmacology with a follow-up in 2008 in the Journal of Psychopharmacology, made news around the globe and was greeted by nearly unanimous praise by both the scientific community and the mainstream press. Flying in the face of both government policy and conventional wisdom, its conclusion — that psychedelic drugs offer the potential for profound, transformative, and long-lasting positive changes in properly prepared individuals — may herald a revival in the study of altered states of consciousness.

Since that study, which was published in 2008, Dr. Griffiths and his colleagues have gone on to give psilocybin to people dealing with cancer and depression, like Dr. Martin, the retired psychologist from Vancouver. Dr. Martin’s experience is fairly typical, Dr. Griffiths said: an improved outlook on life after an experience in which the boundaries between the self and others disappear.

In interviews, Dr. Martin and other subjects described their egos and bodies vanishing as they felt part of some larger state of consciousness in which their personal worries and insecurities vanished. They found themselves reviewing past relationships with lovers and relatives with a new sense of empathy.

“It was a whole personality shift for me,” Dr. Martin said. “I wasn’t any longer attached to my performance and trying to control things. I could see that the really good things in life will happen if you just show up and share your natural enthusiasms with people. You have a feeling of attunement with other people.”

The subjects’ reports mirrored so closely the accounts of religious mystical experiences, Dr. Griffiths said, that it seems likely the human brain is wired to undergo these “unitive” experiences, perhaps because of some evolutionary advantage.

Opiates for the masses may not be far off. Scientists have figured out two of the final steps in the chain of chemical reactions that synthesize morphine in the opium poppy.

Pinpointing the cellular workhorses and the genes involved in making morphine may lead to new production methods for the drug and its chemical cousins such as codeine, oxycodone and buprenorphine, scientists report in a paper published online March 14 in Nature Chemical Biology.

Morphine and its relatives, widely used as painkillers in developed countries, are fairly expensive and are often taken for extended periods of time. The new research may lead to better ways of engineering yeast or other microbes to make these painkillers — perhaps skirting the social and political morass of agricultural poppy production, the source of heroin.

Hart next tried offering these participants the choice between a low dose of meth and a small monetary voucher, at different times of day. The prediction was that, meth being a potent reinforcer, users would take it compulsively; what he found was that people would take it in the morning but not in the evening, when it would stop them sleeping — using it to get through the day in the same way office workers self-administer caffeine; and if the monetary reward was large enough, they would pass up the dose. These findings call into question the notion that addiction is driven by the reward of a chemically induced euphoria and that meth — legally prescribed to treat ADHD, narcolepsy and obesity — is the destructive drug so maligned by the NIDA and the popular press. Hart’s conclusion was that his subjects were indeed making rational choices about their drug use.